stage iib lung cancer ajcc v8
Showing 1 - 25 of 29
Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8, Stage IIA Lung Cancer AJCC v8 Trial in Los Angeles (Atezolizumab
Recruiting
- Lung Non-Small Cell Carcinoma
- +10 more
- Atezolizumab and Recombinant Human Hyaluronidase
- Survey Administration
-
Los Angeles, CaliforniaUSC / Norris Comprehensive Cancer Center
Jan 31, 2023
Localized Lung Carcinoma, Locally Advanced Lung Non-Small Cell Carcinoma, Recurrent Lung Carcinoma Trial in United States
Suspended
- Localized Lung Carcinoma
- +10 more
- Accelerated Hypofractionated Radiation Therapy
- +2 more
-
Atlanta, Georgia
- +55 more
Jan 10, 2023
Non-metastatic, Non-recurrent Lung and Esophageal Cancer
Recruiting
- Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8
- +55 more
- Biospecimen Collection
- +3 more
-
Scottsdale, ArizonaMayo Clinic in Arizona
Jan 5, 2023
Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8, Stage IA1 Lung Cancer AJCC v8 Trial in Buffalo (Best Practice,
Not yet recruiting
- Lung Non-Small Cell Carcinoma
- +8 more
- Best Practice
- +2 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Dec 29, 2022
Locally Advanced Lung Non-Small Cell Carcinoma, Stage IIB Lung Cancer AJCC v8, Stage III Lung Cancer AJCC v8 Trial (drug,
Not yet recruiting
- Locally Advanced Lung Non-Small Cell Carcinoma
- +2 more
- Carboplatin
- +11 more
- (no location specified)
Nov 14, 2022
Caregiver, Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8 Trial in Houston (Educational Intervention,
Recruiting
- Esophageal Carcinoma
- +16 more
- Educational Intervention
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Nov 11, 2022
Locally Advanced Lung Non-Small Cell Carcinoma, Metastatic Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8 Trial in
Recruiting
- Locally Advanced Lung Non-Small Cell Carcinoma
- +12 more
- Computed Tomography
- Contrast Agent
-
New Brunswick, New Jersey
- +1 more
Nov 2, 2022
COPD, Lung Non-Small Cell Carcinoma, Pneumonia Trial in Buffalo (Quality-of-Life Assessment, Questionnaire Administration,
Recruiting
- Chronic Obstructive Pulmonary Disease
- +7 more
- Quality-of-Life Assessment
- +2 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Oct 20, 2022
Clinical Stage 0 Cutaneous Melanoma AJCC v8, Clinical Stage I Cutaneous Melanoma AJCC v8, Clinical Stage IA Cutaneous Melanoma
Recruiting
- Clinical Stage 0 Cutaneous Melanoma AJCC v8
- +43 more
- Best Practice
- +7 more
-
Houston, TexasM D Anderson Cancer Center
Oct 12, 2022
Limited Stage Lung Small Cell Carcinoma, Stage I Lung Cancer AJCC v8, Stage IA1 Lung Cancer AJCC v8 Trial in Japan, United
Recruiting
- Limited Stage Lung Small Cell Carcinoma
- +12 more
- 3-Dimensional Conformal Radiation Therapy
- +7 more
-
Birmingham, Alabama
- +544 more
Aug 24, 2022
Lung Non-Small Cell Carcinoma, Lung Non-Small Cell Squamous Carcinoma, Lung Non-Squamous Non-Small Cell Carcinoma Trial in Guam,
Recruiting
- Lung Non-Small Cell Carcinoma
- +7 more
- Carboplatin
- +8 more
-
Anchorage, Alaska
- +1084 more
Aug 24, 2022
Head and Neck Squamous Cell Carcinoma, Lung Non-Small Cell Carcinoma, Stage I Cutaneous Squamous Cell Carcinoma of the Head and
Not yet recruiting
- Head and Neck Squamous Cell Carcinoma
- +17 more
- Best Practice
- +3 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Aug 19, 2022
Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8, Stage IA1 Lung Cancer AJCC v8 Trial in Atlanta (Durvalumab,
Active, not recruiting
- Lung Non-Small Cell Carcinoma
- +9 more
-
Atlanta, GeorgiaEmory University Hospital/Winship Cancer Institute
Aug 22, 2022
Lung Non-Small Cell Carcinoma, Stage IIB Lung Cancer AJCC v8, Stage IIIA Lung Cancer AJCC v8 Trial in United States (biological,
Recruiting
- Lung Non-Small Cell Carcinoma
- +3 more
- Atezolizumab
- +7 more
-
Jonesboro, Arkansas
- +35 more
Aug 12, 2022
Resectable Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8, Stage IA1 Lung Cancer AJCC v8 Trial in Houston
Terminated
- Resectable Lung Non-Small Cell Carcinoma
- +10 more
- Bintrafusp Alfa
- Therapeutic Conventional Surgery
-
Houston, TexasM D Anderson Cancer Center
Jul 27, 2022
Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8, Stage IA1 Lung Cancer AJCC v8 Trial in Portland (Best Practice,
Recruiting
- Lung Non-Small Cell Carcinoma
- +15 more
- Best Practice
- +2 more
-
Portland, Oregon
- +1 more
Jun 8, 2022
Malignant Female Reproductive System Tumor, Stage 0 Lung Cancer AJCC v8, Stage I Lung Cancer AJCC v8 Trial in Duarte
Active, not recruiting
- Malignant Female Reproductive System Neoplasm
- +16 more
- Educational Intervention
- +2 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jun 7, 2022
Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8 Trial (Nivolumab,
Withdrawn
- Lung Non-Small Cell Carcinoma
- +12 more
- Nivolumab
- Sapanisertib
- (no location specified)
May 24, 2022
Development of Chemotherapy-Induced Peripheral Neuropathy in
Active, not recruiting
- Anatomic Stage I Breast Cancer AJCC v8
- +45 more
- Chemotherapy
- +2 more
-
Antioch, California
- +168 more
May 3, 2022
Locally Advanced Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8, Stage IIA Lung Cancer AJCC v8 Trial in Columbus
Recruiting
- Locally Advanced Lung Non-Small Cell Carcinoma
- +8 more
- Carboplatin
- +4 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Apr 18, 2022
Stage I Lung Cancer AJCC v8, Stage IA1 Lung Cancer AJCC v8, Stage IA2 Lung Cancer AJCC v8 Trial in Buffalo (other, procedure,
Recruiting
- Stage I Lung Cancer AJCC v8
- +9 more
- Best Practice
- +5 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Apr 5, 2022
Lung Non-Small Cell Carcinoma, Stage I Colorectal Cancer AJCC v8, Stage I Lung Cancer AJCC v8 Trial in Duarte (Quality-of-Life
Recruiting
- Lung Non-Small Cell Carcinoma
- +21 more
- Quality-of-Life Assessment
- +3 more
-
Duarte, CaliforniaCity of Hope Medical Center
Apr 5, 2022
Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8, Stage IA1 Lung Cancer AJCC v8 Trial in San Francisco (drug,
Withdrawn
- Lung Non-Small Cell Carcinoma
- +9 more
- Cisplatin
- +4 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Feb 17, 2022
Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8, Stage IA1 Lung Cancer AJCC v8 Trial in New York, Houston (Best
Recruiting
- Lung Non-Small Cell Carcinoma
- +8 more
- Best Practice
- +2 more
-
New York, New York
- +1 more
Jan 18, 2022
Lung Carcinoma, Stage I Lung Cancer AJCC v8, Stage IA1 Lung Cancer AJCC v8 Trial in Houston (Canakinumab, Quality-of-Life
Recruiting
- Lung Carcinoma
- +12 more
- Canakinumab
- Quality-of-Life Assessment
-
Houston, TexasM D Anderson Cancer Center
Nov 17, 2021